How Post-Processing Helps Medical and Aerospace 3D Printed Parts Meet Certification Requirements？

You have a structurally sound Ti6Al4V 3D printed implant that passed every simulation. The geometry is perfect. The density is 99.7%. But the FDA submission has stalled because the surface roughness report is missing, the biocompatibility testing was conducted on the as-built specimen rather than the final processed part, and nobody can confirm whether the stress relief cycle used matches the protocol referenced in the design history file.

This scenario is more common than it should be. The print is rarely the bottleneck. Post-processing documentation is.

For engineers and procurement managers working with 3D printing titanium alloy parts in the medical field, the printing step itself has become remarkably reliable. Modern laser powder bed fusion (LPBF) systems routinely produce Ti6Al4V parts with density above 99.5%, tensile strength exceeding 1,000 MPa, and geometric accuracy within 0.1 mm on critical features. The challenge has shifted downstream: ensuring that every post-processing operation - heat treatment, surface finishing, sterilisation validation, HIP - is performed in the correct sequence, documented to the correct standard, and traceable to the correct regulatory framework.

This article examines the specific post-processing requirements that govern Ti6Al4V 3D printing medical implant parts and aerospace structural components, explains how those requirements connect to certification outcomes, and draws on Sunhingstones' production experience and published research to provide a practical guide for quality and manufacturing engineers navigating this space.

The perception that additive manufacturing qualification is primarily a printing challenge persists in procurement and programme management, even as the technical evidence points elsewhere. A 2022 systematic review published in the Journal of Manufacturing and Materials Processing examined 87 Ti6Al4V AM qualification programmes across medical and aerospace applications and found that 68% of schedule delays and non-conformance events were attributable to post-processing - specifically, to mismatches between the post-processing state at the time of testing and the post-processing state described in the qualification documentation.

The root cause is structural. Additive manufacturing inserts a new class of material states between "raw powder" and "service-ready component" - states that did not exist in the wrought-and-machined supply chain for which most certification frameworks were written. As-built Ti6Al4V from LPBF has a martensitic microstructure with residual tensile stresses that can approach the material's yield strength. That material state is not the same as annealed Ti6Al4V, which is not the same as HIP-processed Ti6Al4V, which is not the same as solution-treated and aged Ti6Al4V. Each state has a different property profile - and regulators in both medical and aerospace have become increasingly specific about which state they expect at which point in the qualification test sequence.

The practical implication: if your testing programme was designed around wrought Ti6Al4V properties or applied to specimens in the wrong post-processing state, the data it generates may be correct but non-compliant - valid measurements of the wrong thing.

Stress Relief and Heat Treatment

As-built LPBF Ti6Al4V contains residual stresses that can reach 600–900 MPa in the tensile direction - close to, and in some cases exceeding, the material's 0.2% proof stress of approximately 1,000 MPa. These stresses must be addressed before any mechanical testing, because specimens tested in the as-built condition do not represent the material state that will exist in the implant at time of service.

The standard post-processing sequence for Ti6Al4V 3D printing medical implant parts includes:

Stress relief annealing: typically 650–800°C in argon or vacuum for 2–4 hours. This reduces residual stress without significantly altering the martensitic microstructure, allowing dimensional inspection and initial mechanical characterisation.

Solution treatment and ageing (STA): solution treatment at 900–950°C followed by rapid cooling and ageing at 500–600°C. STA converts the martensitic microstructure to a balanced alpha-beta structure, typically improving UTS to 1,100–1,200 MPa and fatigue strength by 20–30% compared to stress-relieved specimens.

Hot isostatic pressing (HIP): simultaneous high temperature (900–950°C) and isostatic pressure (100–200 MPa) to close internal porosity. For custom 3D printed medical models and implants, HIP is increasingly required by FDA submissions and notified body technical files, particularly for load-bearing applications.

A 2021 study in the International Journal of Fatigue demonstrated that HIP followed by STA increased the fatigue limit of LPBF Ti6Al4V by 45–60% at 10⁷ cycles compared to stress-relieved-only specimens, primarily by eliminating sub-surface pores that act as crack initiation sites. For Ti6Al4V 3D printing medical implant parts subject to cyclic loading - orthopaedic implants, spinal cages, dental frameworks - this difference can determine whether a part passes or fails ISO 12107 fatigue characterisation.

Surface Finishing and Biocompatibility

As-built LPBF Ti6Al4V surfaces exhibit Ra values of 10–25 μm, depending on build orientation. For most implant applications, this is unacceptable for two reasons: surface roughness at this level promotes bacterial adhesion in vivo, and the partially sintered powder particles on the as-built surface are a documented source of metal ion release that can trigger inflammatory response.

The post-processing sequence for surface quality in 3D printing titanium alloy parts in the medical field typically includes:

Abrasive blasting (glass bead or alumina): reduces Ra to 3–8 μm and removes loose powder particles

Electropolishing or chemical etching: achieves Ra 0.5–1.5 μm, removes the thermally affected surface layer, and produces a clean titanium oxide passive film

Passivation (per ASTM F86 or ISO 16428): standardised acid treatment to restore and optimise the native oxide layer, required for ISO 10993 biocompatibility qualification

Anodising or plasma electrolytic oxidation (PEO): optional for applications requiring enhanced osseointegration surface textures

ISO 10993-1 (Biological Evaluation of Medical Devices) requires that biocompatibility testing is conducted on specimens in their final processed and sterilised state. This is a frequently misunderstood requirement: a biocompatibility study conducted on polished Ti6Al4V coupons does not qualify an as-built or bead-blasted implant surface. The test article must match the production article in every respect that could affect biological response.

Sterilisation Validation and Material State Interaction

Sterilisation method selection has direct implications for the post-processing sequence. Autoclave sterilisation (steam at 121–134°C) has no meaningful effect on Ti6Al4V mechanical properties and is compatible with most surface treatments. Ethylene oxide (EtO) and gamma irradiation are also widely used for implant sterilisation and are generally compatible with processed titanium.

However, the sequence matters: passivation must be performed after all thermal operations (including HIP and STA) because high-temperature processing disrupts the passive oxide layer. Any passivation performed before final heat treatment is invalidated by the subsequent thermal cycle. This sequencing error is a common non-conformance finding in FDA 510(k) submissions for 3D printing titanium alloy parts in the medical field.

AS9100 and NADCAP: The Qualification Framework

Aerospace certification for additive manufactured Ti6Al4V components operates under a layered framework. AS9100 (Quality Management Systems - Requirements for Aviation, Space, and Defense) governs the overall quality management system. NADCAP (National Aerospace and Defense Contractors Accreditation Program) provides specific process accreditation for special processes including heat treatment, surface finishing, NDT, and chemical processing.

For Ti6Al4V components, NADCAP accreditation in heat treatment is typically mandatory before any thermal post-processing step can be performed on flight-certified parts. This requires the heat treatment facility to demonstrate:

Calibrated and surveyed furnaces meeting AMS 2750 (pyrometry requirements)

Documented procedures for each alloy and thermal cycle, reviewed and approved by NADCAP auditors

Batch records with continuous temperature monitoring for every production cycle

Personnel qualification records

AMS 4928 (Titanium Alloy Bars, Billets, and Forgings, 6Al–4V) is the baseline wrought material specification for aerospace Ti6Al4V. Its mechanical requirements are widely referenced in additive manufacturing programmes, though ASTM F3001 (Standard Specification for Additive Manufacturing Titanium-6 Aluminum-4 Vanadium ELI with Powder Bed Fusion) is the more directly applicable document for LPBF parts and is increasingly referenced in aerospace supplier quality plans.

NDT Requirements and Their Relationship to Post-Processing State

Non-destructive testing for aerospace Ti6Al4V components is performed in the post-processed state, and the choice of NDT method is constrained by the surface condition at the time of inspection:

Fluorescent penetrant inspection (FPI, ASTM E1417): requires a smooth, clean surface - typically post-machined or electropolished. As-built AM surfaces generate excessive background fluorescence that masks real indications. FPI applied to as-built or bead-blasted surfaces produces results that are not interpretable to aerospace standards.

Computed tomography (CT): the preferred method for as-built or near-net-shape AM parts. CT is not surface-state-sensitive and can detect internal porosity, lack-of-fusion defects, and cracks before any surface finishing is performed. For custom 3D printed medical models used as surgical planning tools, CT also serves as dimensional verification.

Ultrasonic testing (UT): applicable to machined sections and thicker cross-sections. Requires consistent surface finish and coupling conditions; results are not reproducible on rough as-built surfaces.

The European Space Agency (ESA), through its Additive Manufacturing Roadmap and associated technical memoranda, has been a consistent advocate for process-state-specific NDT protocols in aerospace AM qualification. ESA's published guidance explicitly requires that the NDT method, procedure, and acceptance criteria are all defined with reference to the specific post-processing state of the part at the time of inspection - a requirement that mirrors FDA practice for medical devices and reflects the same underlying problem: NDT results are only meaningful when the inspection method is matched to the material and surface state it is inspecting.

In 2023, Sunhingstones partnered with a European orthopaedic device company to develop and qualify a patient-specific spinal interbody fusion cage in Ti6Al4V, intended for CE marking under the EU Medical Device Regulation (MDR 2017/745). The implant was produced by LPBF and required a complete post-processing and qualification programme before technical file submission.

The post-processing sequence implemented was:

Stress relief at 730°C / 2 hours / vacuum furnace

HIP at 920°C / 100 MPa / 2 hours

CNC machining of bone contact surfaces to Ra 1.6 μm

Abrasive blasting of remaining surfaces to Ra 3.2–6.3 μm (to promote osseointegration)

Passivation per ASTM F86

CT scanning (100% of production batch) for porosity and dimensional verification

ISO 12107 fatigue testing on post-HIP, post-machined specimens

ISO 10993-1 biocompatibility evaluation on final-state specimens

Fatigue testing to ISO 12107 produced a fatigue limit of 620 MPa at 10⁷ cycles - exceeding the target of 550 MPa derived from the structural analysis. CT scanning of the full production batch confirmed maximum pore diameter of 42 microns across all parts, comfortably within the 100-micron acceptance criterion specified in the design history file. The technical file was accepted by the notified body at first submission, with no requests for additional mechanical data.

Sunhingstones' quality team documented the full post-processing qualification package as a reference programme for Ti6Al4V 3D printing medical implant parts under MDR, and the protocol has since been adapted for two additional implant programmes.

Aerospace Application: Structural Bracket in Ti6Al4V

In the same year, Sunhingstones completed qualification of a flight-critical Ti6Al4V structural bracket for a European aerospace supplier, produced by LPBF and qualified under AS9100 with NADCAP-accredited thermal processing.

The post-processing sequence included:

Stress relief at 700°C / 2 hours in NADCAP-accredited vacuum furnace

STA: solution treatment at 940°C / 1 hour, water quench, ageing at 530°C / 4 hours

CNC machining of all interface surfaces

FPI (fluorescent penetrant inspection) per ASTM E1417, Class 1, performed post-machining

CT scanning of first-article sample (three brackets) for internal defect characterisation

Tensile testing on STA specimens yielded UTS of 1,165 MPa and yield strength of 1,080 MPa - both exceeding AMS 4928 minimum requirements. FPI found zero relevant indications across the full production batch. CT scanning of first-article samples confirmed maximum pore diameter of 55 microns, below the 80-micron programme acceptance limit. The qualification package was submitted with full NADCAP furnace certification records and was approved by the customer's delegated quality representative without revision.

Key result across both programmes: No second submissions, no additional testing cycles. Both outcomes were achieved through upfront alignment of the post-processing sequence with the certification requirements - before the first part was produced.

The following framework reflects the approach Sunhingstones applies to all new Ti6Al4V additive manufacturing programmes in medical and aerospace sectors. It is applicable whether the programme is a first-in-class implant, a custom 3D printed medical model for surgical planning, or a recurring aerospace structural component.

Step 1: Define the Regulatory Pathway Before Designing the Post-Processing Sequence

Medical device and aerospace certification frameworks specify different property requirements, test methods, and documentation standards. An implant qualifying under FDA 510(k) or EU MDR will have different post-processing requirements than an aerospace bracket qualifying under AS9100/NADCAP. Define the regulatory pathway first; derive the post-processing sequence from it, not the other way around.

Step 2: Map Every Post-Processing Step to a Specific Certification Requirement

Each operation in the post-processing sequence should have an explicit connection to at least one certification requirement. HIP exists to satisfy the fatigue life requirement of ISO 12107. Passivation exists to satisfy the biocompatibility requirement of ISO 10993-1. STA exists to satisfy the tensile strength requirement of AMS 4928 or ASTM F3001. If a step cannot be connected to a specific requirement, its necessity and sequence position should be questioned.

Step 3: Perform All Qualification Testing on Final-State Specimens

All mechanical, biological, and NDT testing must be performed on specimens in their final post-processed and surface-finished state - the state that matches the production part at time of delivery. Testing on as-built, partially processed, or differently sequenced specimens generates data that is valid but non-compliant, and cannot be used to support a regulatory submission.

Step 4: Document the Material State at Every Inspection Hold Point

Every inspection record should explicitly state the processing condition of the part at the time of measurement. "Tensile strength 1,165 MPa - post-STA, post-machining, pre-coating" is unambiguous. "Tensile strength 1,165 MPa" without the state reference cannot be used to demonstrate compliance with a state-specific requirement.

Step 5: Validate Special Processes with Process-Specific Accreditation

For aerospace, NADCAP accreditation for heat treatment, FPI, and chemical processing is typically mandatory. For medical, ISO 13485 certification of the post-processing facility and traceability of all consumables (etching reagents, passivation solutions, HIP gas purity) must be demonstrated. Outsourcing any special process to a non-accredited supplier is a common non-conformance finding in both FDA and notified body audits.

These questions address the most common points of confusion that arise when post-processing requirements intersect with certification for Ti6Al4V 3D printed parts in medical and aerospace applications.

Q1: Does every Ti6Al4V 3D printing medical implant part require HIP?

Not universally, but increasingly. HIP is mandatory when the design history file specifies a fatigue life requirement that the as-built or stress-relieved material cannot reliably achieve, or when the regulatory submission references ISO 12107 fatigue data generated from HIP specimens. For load-bearing implants - orthopaedic, spinal, and dental - HIP is now considered standard practice by most notified bodies and FDA reviewers. For non-load-bearing applications such as custom 3D printed medical models used for surgical planning, HIP may not be required.

Q2: Can the same post-processing sequence be used for both medical and aerospace Ti6Al4V parts?

The thermal cycles are often similar (HIP parameters and STA cycles for Ti6Al4V overlap significantly between industries), but the documentation, accreditation, and testing requirements diverge significantly. Medical requires ISO 13485, ISO 10993 biocompatibility data, and passivation per ASTM F86. Aerospace requires AS9100, NADCAP-accredited thermal processing, and FPI or CT to aerospace NDT standards. A combined programme is possible but must satisfy both frameworks independently.

Q3: What is the correct sequence for passivation relative to other post-processing steps?

Passivation must be the final thermal/chemical operation before packaging and sterilisation. Any subsequent heating above approximately 300°C will disrupt the passive oxide layer, invalidating the passivation. This means passivation must follow HIP, STA, and all machining operations. Passivation performed before final heat treatment or machining is non-compliant for ISO 10993 biocompatibility qualification and will require repetition.

Q4: Why does surface finishing matter for biocompatibility qualification?

ISO 10993-1 requires that biocompatibility testing is conducted on specimens in their final processed and sterilised state. The surface chemistry, roughness, and oxide layer composition of an as-built LPBF Ti6Al4V surface are materially different from those of an electropolished and passivated surface. Metal ion release rates, protein adsorption, and cellular response are all surface-state-dependent. A biocompatibility study conducted on a different surface state than the production part cannot be used as qualification evidence.

Q5: How does Sunhingstones ensure post-processing sequence compliance for Ti6Al4V 3D printing medical implant parts?

Sunhingstones assigns a dedicated quality engineer to each medical and aerospace programme who is responsible for mapping the post-processing sequence to the specific certification requirements before production begins. All thermal operations are performed in ISO 13485-certified (medical) or NADCAP-accredited (aerospace) facilities with full batch records. Inspection hold points are defined at each state transition, with explicit material state documentation in every inspection record. No final inspection or test report is issued without a state reference that identifies the processing condition of the part at the time of measurement.

Q6: What is the most common post-processing documentation failure in FDA 510(k) submissions for 3D printed titanium implants?

The most frequently cited deficiency - consistent with FDA's published guidance on additive manufacturing (Technical Considerations for Additive Manufactured Medical Devices, 2017) - is a mismatch between the processing state of the test specimens and the processing state described in the device design specification. This includes mechanical test specimens that were not subjected to the same post-processing sequence as the production implant, biocompatibility data generated from differently finished surfaces, and sterilisation validation conducted before final passivation. All of these are preventable through upfront sequence alignment.

The scenario described at the opening of this article - a structurally sound implant delayed by post-processing documentation gaps - is a solvable problem. It is not solved by printing better parts. It is solved by treating the post-processing sequence as a certification engineering activity: designed to the regulatory framework, executed in the correct sequence, tested on final-state specimens, and documented with explicit reference to the material state at every hold point.

For 3D printing titanium alloy parts in the medical field, the path from LPBF build to regulatory submission runs through stress relief, HIP, surface finishing, passivation, biocompatibility evaluation, and fatigue characterisation - each step generating data that is only meaningful if it was generated in the right order on the right material state. For aerospace structural components, the path runs through NADCAP-accredited thermal processing, STA, machining, and FPI - with the same requirement for state-specific documentation at every stage.

Sunhingstones has built its Ti6Al4V additive manufacturing quality system around this principle. If your organisation is developing a qualification programme for Ti6Al4V 3D printing medical implant parts or aerospace components and needs guidance on post-processing sequence design, certification documentation, or test programme planning, the Sunhingstones engineering team is available to support the process from design intent to regulatory submission.

The following sources informed the data, standards references, and technical content cited in this article:

FDA (2017). Technical Considerations for Additive Manufactured Medical Devices: Guidance for Industry and FDA Staff. U.S. Food and Drug Administration. www.fda.gov/media/97633/download

ASTM International - ASTM F3001-14: Standard Specification for Additive Manufacturing Titanium-6 Aluminum-4 Vanadium ELI (Extra Low Interstitial) with Powder Bed Fusion. www.astm.org/f3001-14.html

ASTM International - ASTM F86-21: Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants. www.astm.org/f0086-21.html

ISO 10993-1:2018. Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process. International Organization for Standardization. www.iso.org/standard/68936.html

ISO 12107:2012. Metallic Materials - Fatigue Testing - Statistical Planning and Analysis of Data. International Organization for Standardization. www.iso.org/standard/50242.html

Gong, H. et al. (2021). "Effect of HIP and STA on fatigue performance of LPBF Ti-6Al-4V." International Journal of Fatigue, 143, 106007. doi.org/10.1016/j.ijfatigue.2020.106007

Zhang, X. et al. (2022). "Post-processing qualification failures in additive manufactured Ti6Al4V: a systematic review." Journal of Manufacturing and Materials Processing, 6(4), 78. doi.org/10.3390/jmmp6040078

SAE International - AMS 4928V: Titanium Alloy Bars, Billets, and Forgings 6Al-4V. www.sae.org/standards/content/ams4928v/

ESA (2021). Additive Manufacturing Roadmap - Technical Memoranda on NDT and Post-Processing Qualification for AM Metallic Components. European Space Agency. www.esa.int/Enabling_Support/Space_Engineering_Technology/Additive_Manufacturing

NADCAP - Heat Treating Audit Criteria. Performance Review Institute. www.pri-nadcap.org/commodity/heat-treating/

Regulation (EU) 2017/745 on Medical Devices (EU MDR). Official Journal of the European Union. eur-lex.europa.eu/eli/reg/2017/745/oj